BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Visible Genetics Incorporated

Founded in 1993, VGI is a world leader in the emerging field of pharmacogenomics: the use of genetic information to individualize medicine. We develop, manufacture and market high-performance automated sequencing systems for the analysis of genes linked to disease, with the goal of improving the clinical management and quality of life of patients. Our primary focus is currently on viral diseases, such as HIV and hepatitis, but we are also researching other diseases, including cancer. VGI currently has over 300 employees worldwide with extensive experience in the areas of genetic research, virology, oncology, engineering, manufacturing, software development, bioinformatics, product development, sales and marketing, medical and regulatory affairs, clinical research and finance.



Corporate headquarters and software development are located in Toronto, Canada. Manufacturing, development and US headquarters are located in Suwanee, near Atlanta, GA, USA. European headquarters are located in High Wycombe, UK and Research is in Cambridge, UK. We also have offices in France, Spain, Italy, Portugal and Israel.


Contact Details:
700 Bay Street Suite 1000
Toronto
Ontario
M5G 1Z6 C
Canada
Tel:416 813 3240
Fax:416 813 3262
Email:
WWW:

www.isinet.com/




Loading...

Recent Publications by Visible Genetics Incorporated:

A general approach to the analysis of errors and failure modes in the base-calling function in automated fluorescent DNA sequencing.
We describe the analysis of errors and failure modes in the base-calling...
12th July, 2003
Visible Genetics Inc., 700 Bay Street, Suite 1000, Toronto, Ontario M5G Electrophoresis. 2002 Aug;23(16):2720-8.
DOI Direct Link
Molecular genotyping of hepatitis B virus.
The development of new therapeutic agents against hepatitis B virus (HBV)...
4th March, 2003
Visible Genetics, Inc., 184 Cambridge Science Park, Cambridge CB4 0GA, UK. J Clin Virol. 2002 Dec;25 Suppl 3:S41-5.
Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
A previous study of 48 primary non-small cell lung carcinomas (NSCLC) for...
31st January, 2003
Visible Genetics Inc., 700 Bay Street, Suite 1000, Box 333, Toronto, Int J Oncol. 1998 Jan;12(1):107-11.
High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer.
The Visible Genetics Clipper sequencer is a new platform for automated DNA...
12th August, 2000
Visible Electrophoresis. 1999 Jun;20(6):1280-300.
DOI Direct Link

BioNews Results for Visible Genetics Incorporated:

High Growth Forecasted for the In Vitro Diagnostics Market Report and Analysis 2008-2023
Interest!ALERT:  Sep 5 2008 8:03PM Matching: visible genetics

Visible Genetics Incorporated Patents:

US Patent No.Title
5776737 Method and composition for internal identification of samples
5916747 Method and apparatus for alignment of signals for use in DNA based-calling
5981186 Method and apparatus for DNA-sequencing using reduced number of sequencing mixtures
6005663 Automated electrophoresis and fluorescence detection apparatus and method
6007689 Apparatus for preparing gels for use in electrophoretic separations and similar applications

View more Visible Genetics Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 232 times since April 2007, the link to the organisation's website has been followed 47 times

Recent Search Terms used to find this page: visible genetics uk | visible genetics ltd high wycombe | t | visible genetics cambridge | visible genetics incorporated | visible genetics High Wycombe | visible genetics 700 bay street canada | .

Search for more companies in Toronto

Search for more companies in Ontario



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Visible Genetics Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.